These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 27565924)
1. Drug-induced myocarditis after nivolumab treatment in a patient with PDL1- negative squamous cell carcinoma of the lung. Semper H; Muehlberg F; Schulz-Menger J; Allewelt M; Grohé C Lung Cancer; 2016 Sep; 99():117-9. PubMed ID: 27565924 [TBL] [Abstract][Full Text] [Related]
2. Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature. Ruiz-Bañobre J; Pérez-Pampín E; García-González J; Gómez-Caamaño A; Barón-Duarte FJ; López-López R; Vázquez-Rivera F Lung Cancer; 2017 Jun; 108():217-221. PubMed ID: 28625638 [TBL] [Abstract][Full Text] [Related]
3. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report. Li H; Ma W; Yoneda KY; Moore EH; Zhang Y; Pu LL; Frampton GM; Molmen M; Stephens PJ; Li T J Hematol Oncol; 2017 Feb; 10(1):64. PubMed ID: 28245875 [TBL] [Abstract][Full Text] [Related]
4. Nivolumab-induced organizing pneumonitis in a patient with lung sarcomatoid carcinoma. Gounant V; Brosseau S; Naltet C; Opsomer MA; Antoine M; Danel C; Khalil A; Cadranel J; Zalcman G Lung Cancer; 2016 Sep; 99():162-5. PubMed ID: 27565934 [TBL] [Abstract][Full Text] [Related]
5. A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia. Fujimoto D; Morimoto T; Ito J; Sato Y; Ito M; Teraoka S; Otsuka K; Nagata K; Nakagawa A; Tomii K Lung Cancer; 2017 Sep; 111():1-5. PubMed ID: 28838377 [TBL] [Abstract][Full Text] [Related]
6. Long-lasting shrinkage in tumor mass after discontinuation of nivolumab treatment. Kimura H; Sone T; Murata A; Koba H; Tambo Y; Hara J; Abo M; Kasahara K Lung Cancer; 2017 Jun; 108():7-8. PubMed ID: 28625651 [TBL] [Abstract][Full Text] [Related]
7. Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer. Kato T; Masuda N; Nakanishi Y; Takahashi M; Hida T; Sakai H; Atagi S; Fujita S; Tanaka H; Takeda K; Satouchi M; Namba Y; Tamura T Lung Cancer; 2017 Feb; 104():111-118. PubMed ID: 28212992 [TBL] [Abstract][Full Text] [Related]
8. Immune-related pancreatitis secondary to nivolumab in a patient with recurrent lung adenocarcinoma: A case report. Ikeuchi K; Okuma Y; Tabata T Lung Cancer; 2016 Sep; 99():148-50. PubMed ID: 27565931 [TBL] [Abstract][Full Text] [Related]
9. Acquired Hemophilia A After Nivolumab Therapy in a Patient With Metastatic Squamous Cell Carcinoma of the Lung Successfully Managed With Rituximab. Gokozan HN; Friedman JD; Schmaier AH; Downes KA; Farah LA; Reeves HM Clin Lung Cancer; 2019 Sep; 20(5):e560-e563. PubMed ID: 31311716 [No Abstract] [Full Text] [Related]
10. Symptomatic leptomeningeal metastasis improvement with nivolumab in advanced non-small cell lung cancer patient. Gion M; Remon J; Caramella C; Soria JC; Besse B Lung Cancer; 2017 Jun; 108():72-74. PubMed ID: 28625652 [TBL] [Abstract][Full Text] [Related]
11. Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer. Dasanu CA; Lippman SM; Plaxe SC J Oncol Pharm Pract; 2017 Dec; 23(8):638-640. PubMed ID: 27824586 [TBL] [Abstract][Full Text] [Related]
12. Nivolumab-induced Myocarditis Successfully Treated with Corticosteroid Therapy: A Case Report and Review of the Literature. Matsuo K; Ishiguro T; Najama T; Shimizu Y; Kobayashi Y; Mutou M Intern Med; 2019 Aug; 58(16):2367-2372. PubMed ID: 31118387 [TBL] [Abstract][Full Text] [Related]
13. Severe agranulocytosis in a patient with metastatic non-small-cell lung cancer treated with nivolumab. Tabchi S; Weng X; Blais N Lung Cancer; 2016 Sep; 99():123-6. PubMed ID: 27565926 [TBL] [Abstract][Full Text] [Related]
14. Recurrent dysphasia due to nivolumab-induced encephalopathy with presence of Hu autoantibody. Raskin J; Masrori P; Cant A; Snoeckx A; Hiddinga B; Kohl S; Janssens A; Cras P; Van Meerbeeck JP Lung Cancer; 2017 Jul; 109():74-77. PubMed ID: 28577954 [TBL] [Abstract][Full Text] [Related]
15. Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases. Dudnik E; Yust-Katz S; Nechushtan H; Goldstein DA; Zer A; Flex D; Siegal T; Peled N Lung Cancer; 2016 Aug; 98():114-117. PubMed ID: 27393516 [TBL] [Abstract][Full Text] [Related]
17. Rapid and partial remission of primary lesion but complicated by secondary fibrosis after treatment with nivolumab in a lung squamous carcinoma. Ding L; Zhu Y; Chen C Ther Adv Respir Dis; 2017 Feb; 11(2):129-132. PubMed ID: 27903791 [No Abstract] [Full Text] [Related]
18. Coincidence of immunotherapy-associated hemophagocytic syndrome and rapid tumor regression. Takeshita M; Anai S; Mishima S; Inoue K Ann Oncol; 2017 Jan; 28(1):186-189. PubMed ID: 28043982 [No Abstract] [Full Text] [Related]
19. Fatal association of fulminant myocarditis and rhabdomyolysis after immune checkpoint blockade. Tomoaia R; Beyer RȘ; Pop D; Minciună IA; Dădârlat-Pop A Eur J Cancer; 2020 Jun; 132():224-227. PubMed ID: 32336614 [No Abstract] [Full Text] [Related]
20. [Fulminant myocarditis caused by nivolumab treatment for non-small cell lung cancer (NSCLC): a case report]. Tan KX; Li CY; Zhang JY; Cui HJ; Shen W; Zhang X; Sun CY; Jiang XJ; Zheng SY; Li J; Xue CX Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1047-1048. PubMed ID: 33342162 [No Abstract] [Full Text] [Related] [Next] [New Search]